Female underrepresentation and adverse events reporting biases in lung cancer clinical trials: a systematic review and meta-analysis
{{output}}
Objective: Despite regulatory initiatives to improve female representation in clinical trials, sex-based disparities persist, particularly in oncology. This is of concern given the rising burden of lung cancer in women. We aimed ... ...
